Anti-aging Gene Klotho: A Novel Therapeutic Target for Calcific Aortic Valve Dise
Anti-aging Gene Klotho: A Novel Therapeutic Target for Calcific Aortic Valve Dise
批准号:
8814275
负责人:
Zhongjie Sun
金额:
$36.45万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-03-01 至 2018-02-28
关键词:
AbbreviationsAddressAdultAffectAgeAgingAging-Related ProcessAlkaline PhosphataseAnimal ModelAortic Valve StenosisAttenuatedCardiovascular DiseasesCell Adhesion MoleculesChronic Kidney FailureCollagenComplementCoupledDepositionDevelopmentDiabetes MellitusDiseaseEndothelial CellsEnvironmentEtiologyFailureGene DeliveryGenesGeneticGoalsHeart DiseasesHigh PrevalenceHumanHypertensionInbred StrainInflammationKidneyKnock-outLongevityMatrix MetalloproteinasesMedicalMolecularMusMutationOperative Surgical ProceduresOxidative StressPathogenesisPatientsPopulationPrevalencePrevention strategyProteinsResearchResistanceRisk FactorsRoleSerumSurgical ValvesSymptomsTestingTherapeuticWorkagedaging geneanti agingaortic valveaortic valve disorderaortic valve replacementcalcificationendothelial dysfunctionin vivoinnovationinsightklotho proteinmatrix Gla proteinmortalitynew therapeutic targetnovelpreventpublic health relevancescleraxissenescencetranscription factorvalve replacement
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The mounting prevalence of risk factors such as aging, diabetes, and hypertension, coupled with genetic factors can perturb the cellular and molecular mechanism of the aortic valves leading to calcific aortic valve disease (CAVD) and ultimately aortic stenosis. Surgical replacement of the aortic valve remains the only and the last choice for the disease. Over 30,000 aortic valves were replaced in 2009. Patients with severe aortic stenosis who do not receive surgical valve replacement have a mortality rate of 37% at one year after symptom onset. However, replacement valves are susceptible to failure, necessitating additional surgeries. There currently is no effective medical therapy for CAVD due to the unknown etiology of the disease. Therefore, a conceptual breakthrough to develop novel targets and strategies to develop a cure for CAVD is paramount. Klotho is a recently-discovered anti- aging gene and is predominately expressed in kidneys. Klotho is a secreted protein. The level of circulating klotho declines in the aged population while the prevalence of CAVD increases in the aged population. The objective of this application is to determine, in animal models, if klotho deficiency is a causal factor of CAVD and if klotho gene delivery or klotho protein supplement could serve as an effective therapeutic strategy for CAVD. We will accomplish this objective by pursuing the following two complement specific aims. (1) Determine if klotho deficiency causes CAVD and investigate its molecular mechanism. (2) Investigate the hypothesis that in vivo klotho gene or protein delivery will attenuate or reverse CAVD in senescence-accelerated mice. The proposed work is innovative and significant because it utilizes state-of-the-art approaches to address CAVD which affects a large aged population but remains poorly explored. The results will reveal a novel etiological factor for senescence-related CAVD. The proposed research will provide important insights into therapeutic strategies for CAVD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigation into Arterial Stiffness and Hypertension
-
批准号:10463821
-
项目类别:
-
资助金额:$56.78万
-
财政年份:2020
-
负责人:Zhongjie Sun
-
依托单位:
Investigation into Arterial Stiffness and Hypertension
-
批准号:10053836
-
项目类别:
-
资助金额:$55.93万
-
财政年份:2020
-
负责人:Zhongjie Sun
-
依托单位:
Investigation into Arterial Stiffness and Hypertension
-
批准号:10678777
-
项目类别:
-
资助金额:$55.93万
-
财政年份:2020
-
负责人:Zhongjie Sun
-
依托单位:
Investigation into Arterial Stiffness and Hypertension
-
批准号:10251335
-
项目类别:
-
资助金额:$55.93万
-
财政年份:2020
-
负责人:Zhongjie Sun
-
依托单位:
Epigenetic Regulation of Kidney Function and Blood Pressure
-
批准号:10361558
-
项目类别:
-
资助金额:$44.88万
-
财政年份:2019
-
负责人:Zhongjie Sun
-
依托单位:
Epigenetic Regulation of Kidney Function and Blood Pressure
-
批准号:10113501
-
项目类别:
-
资助金额:$45.51万
-
财政年份:2019
-
负责人:Zhongjie Sun
-
依托单位:
Epigenetic Regulation of Kidney Function and Blood Pressure
-
批准号:9916697
-
项目类别:
-
资助金额:$44.76万
-
财政年份:2019
-
负责人:Zhongjie Sun
-
依托单位:
Epigenetic Regulation of Kidney Function and Blood Pressure
-
批准号:10579236
-
项目类别:
-
资助金额:$44.94万
-
财政年份:2019
-
负责人:Zhongjie Sun
-
依托单位:
Epigenetic Regulation of Kidney Function and Blood Pressure
-
批准号:9765836
-
项目类别:
-
资助金额:$47.96万
-
财政年份:2019
-
负责人:Zhongjie Sun
-
依托单位:
Pilot Project Program
-
批准号:10219296
-
项目类别:
-
资助金额:$24.12万
-
财政年份:2017
-
负责人:Zhongjie Sun
-
依托单位:
Investigation into Heart Aging
-
批准号:9027562
-
项目类别:
-
资助金额:$46.82万
-
财政年份:2016
-
负责人:Zhongjie Sun
-
依托单位:
Coupling Factor 6 in Cold-induced Kidney Dysfunction and Hypertension
-
批准号:9095456
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2015
-
负责人:Zhongjie Sun
-
依托单位:
Coupling Factor 6 in Cold-induced Kidney Dysfunction and Hypertension
-
批准号:8911070
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2015
-
负责人:Zhongjie Sun
-
依托单位:
Coupling Factor 6 in Cold-induced Kidney Dysfunction and Hypertension
-
批准号:9276511
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2015
-
负责人:Zhongjie Sun
-
依托单位:
Anti-aging Gene Klotho: A Novel Therapeutic Target for Calcific Aortic Valve Dise
-
批准号:9220847
-
项目类别:
-
资助金额:$23.14万
-
财政年份:2014
-
负责人:Zhongjie Sun
-
依托单位:
Anti-aging gene klotho: a novel therapeutic target in calcific aortic valve disease
-
批准号:9693998
-
项目类别:
-
资助金额:$13.86万
-
财政年份:2014
-
负责人:Zhongjie Sun
-
依托单位:
Investigation into Cold-induced Pulmonary Vascular Inflammation and Dysfunction
-
批准号:8722020
-
项目类别:
-
资助金额:$35.68万
-
财政年份:2013
-
负责人:Zhongjie Sun
-
依托单位:
Investigation into Cold-induced Pulmonary Vascular Inflammation and Dysfunction
-
批准号:8574110
-
项目类别:
-
资助金额:$34.66万
-
财政年份:2013
-
负责人:Zhongjie Sun
-
依托单位:
Investigation into Cold-induced Pulmonary Vascular Inflammation and Dysfunction
-
批准号:8890193
-
项目类别:
-
资助金额:$35.86万
-
财政年份:2013
-
负责人:Zhongjie Sun
-
依托单位:
Investigation into Cold-induced Pulmonary Vascular Inflammation and Dysfunction
-
批准号:9102163
-
项目类别:
-
资助金额:$30.04万
-
财政年份:2013
-
负责人:Zhongjie Sun
-
依托单位:
海外基金